Skip to main content

Market Overview

Fate Therapeutics (NASDAQ: FATE)

77.99 -1.02 (-1.29%)

Analyst Ratings

DateResearch FirmActionCurrentPT
3/12/21SVB LeerinkMaintainsOutperform121.0
3/04/21Wells FargoMaintainsOverweight130.0
2/26/21WedbushDowngradesNeutral
2/25/21Cantor FitzgeraldMaintainsOverweight98.0
2/25/21MizuhoMaintainsBuy109.0
2/17/21Piper SandlerMaintainsOverweight116.0
1/27/21HC Wainwright & Co.AssumesNeutral108.0
12/07/20SVB LeerinkMaintainsOutperform58.0
11/06/20BMO CapitalMaintainsMarket Perform43.0
8/13/20Cantor FitzgeraldMaintainsOverweight40.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter